Details of the Drug Formulaction

General Information of Drug Formulation (ID: F08293)

• Formulation Name: Flecainide 50 mg tablet
• Company: Barr Laboratories

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Flecainide	(DMSQDLE)	Tachyarrhythmias	BC71	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium stearyl fumarate	(E00545)	23665634	lubricant